Combination Therapy of Intravenous Maxacalcitol and Percutaneous Ethanol Injection Therapy Lowers Serum Parathyroid Hormone Level and Calcium × Phosphorus Product in Secondary Hyperparathyroidism

Publisher： Karger

E-ISSN： 1660-2110|102|1|c1-c7

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.102, Iss.1, 2005-09, pp. : c1-c7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relationship between Reductions in Parathyroid Hormone and Serum Phosphorus during the Management of Secondary Hyperparathyroidism with Calcimimetics in Hemodialysis Patients

By  

Nephron Clin Pract, Vol. 121, Iss. 3-4, 2012-11 ,pp. : c124-c130

Karger

Access to resources Recommend Favorite

Serum parathyroid hormone and alkaline phosphatase as predictors of calcium requirements after total parathyroidectomy for hypocalcemia in secondary hyperparathyroidism

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 40, Iss. 2, 2018-02 ,pp. : 324-329

John Wiley & Sons Inc

Access to resources Recommend Favorite

By  

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 4, 2015-08 ,pp. : 367-377

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravenous Calcitriol Therapy Increases Serum Concentrations of Fibroblast Growth Factor-23 in Dialysis Patients with Secondary Hyperparathyroidism

By  

Nephron Clin Pract, Vol. 101, Iss. 2, 2005-06 ,pp. : c94-c99

Karger

Access to resources Recommend Favorite

Comparison of Paricalcitol With Maxacalcitol Injection in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism

By  

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 3, 2015-06 ,pp. : 225-234

John Wiley & Sons Inc

Access to resources Recommend Favorite